Search: onr:"swepub:oai:lup.lub.lu.se:174643a4-1b9b-4921-a97c-d07927240636" >
Dysregulation of El...
Dysregulation of Elongation Factor 1A Expression is Correlated with Synaptic Plasticity Impairments in Alzheimer's Disease
-
- Beckelman, Brenna C. (author)
- Wake Forest University
-
- Day, Stephen (author)
- Wake Forest University
-
- Zhou, Xueyan (author)
- Wake Forest University
-
show more...
-
- Donohue, Maggie (author)
- New York University
-
- Gouras, Gunnar K. (author)
- Lund University,Lunds universitet,Experimentell demensforskning,Forskargrupper vid Lunds universitet,Kansli för experimentell medicinsk vetenskap,Institutionen för experimentell medicinsk vetenskap,Medicinska fakulteten,Experimental Dementia Research,Lund University Research Groups,Department Office of Experimental Medical Science,Department of Experimental Medical Science,Faculty of Medicine
-
- Klann, Eric (author)
- New York University
-
- Keene, C. Dirk (author)
- Washington University School of Medicine
-
- Ma, Tao (author)
- Wake Forest University
-
show less...
-
(creator_code:org_t)
- 2016
- 2016
- English 10 s.
-
In: Journal of Alzheimer's Disease. - 1387-2877. ; 54:2, s. 669-678
- Related links:
-
http://dx.doi.org/10...
-
show more...
-
https://lup.lub.lu.s...
-
https://doi.org/10.3...
-
show less...
Abstract
Subject headings
Close
- Synaptic dysfunction may represent an early and crucial pathophysiology in Alzheimer's disease (AD). Recent studies implicate a connection between synaptic plasticity deficits and compromised capacity of de novo protein synthesis in AD. The mRNA translational factor eukaryotic elongation factor 1A (eEF1A) is critically involved in several forms of long-lasting synaptic plasticity. By examining postmortem human brain samples, a transgenic mouse model, and application of synthetic human Aβ42 on mouse hippocampal slices, we demonstrated that eEF1A protein levels were significantly decreased in AD, particularly in the hippocampus. In contrast, brain levels of eukaryotic elongation factor 2 were unaltered in AD. Further, upregulation of eEF1A expression by the adenylyl cyclase activator forskolin, which induces long-lasting synaptic plasticity, was blunted in hippocampal slices derived from Tg2576 AD model mice. Finally, Aβ-induced hippocampal long-term potentiation defects were alleviated by upregulation of eEF1A signaling via brain-specific knockdown of the gene encoding tuberous sclerosis 2. In summary, our findings suggest a strong correlation between the dysregulation of eEF1A synthesis and AD-associated synaptic failure. These findings provide insights into the understanding of molecular mechanisms underlying AD etiology and may aid in identification of novel biomarkers and therapeutic targets.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Neurosciences (hsv//eng)
Keyword
- Alzheimer's disease
- elongation factor
- long-term potentiation
- mTOR
- protein synthesis
- synaptic plasticity
Publication and Content Type
- art (subject category)
- ref (subject category)
Find in a library
To the university's database